LM

Leslie Mi Ok Chong

Imugene Limited | Chief Executive Officer, Managing Director
Ms Chong joined the Group in September 2015 from the oncology clinical development company, Genentech (a member of the Roche family), where she was a Senior Clinical Program Lead at the head office in San Francisco. She has over 25 years of experience in clinical and department development in oncology.

Company and Roles

Company
Title
Tenure
Since
IMU
Imugene Limited
  • Chief Executive Officer
  • Managing Director
9yrs, 7mthNov 2016

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IMU
Imugene Limited
30/06/263,269,284220,718174,020N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IMU
Imugene Limited
30/06/26
Expiry
508,824$0.115$58,514Options expired
IMU
Imugene Limited
14/05/26
Buy
355,164$0.102$36,404On-market trade
IMU
Imugene Limited
11/05/26
Buy
230,285$0.107$24,755On-market trade
IMU
Imugene Limited
16/04/26
Buy
65,053$0.145$9,432On-market trade
IMU
Imugene Limited
15/12/25
Issued
751,621$0.315$236,760Employee Share Ownership Plan